# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
NextGen Healthcare (NASDAQ:NXGN) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0...
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
https://www.bloomberg.com/news/articles/2023-09-08/thoma-bravo-mulls-1-billion-private-credit-loan-for-nextgen-acquisition#xj4y...
Truist Securities analyst Jailendra Singh maintains NextGen Healthcare (NASDAQ:NXGN) with a Hold and raises the price target...
RBC Capital analyst Sean Dodge maintains NextGen Healthcare (NASDAQ:NXGN) with a Sector Perform and raises the price target ...
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through...
Thoma Bravo, a software investment firm, agreed to acquire NextGen Healthcare Inc (NASDAQ: NXGN) for $23.95
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Wednesday. Here are some big stocks recording gains i...